Epoch Investment Partners Inc. raised its position in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC - Free Report) by 24.1% in the first quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 808,914 shares of the company's stock after purchasing an additional 157,076 shares during the quarter. Epoch Investment Partners Inc. owned 0.18% of GE HealthCare Technologies worth $65,287,000 as of its most recent SEC filing.
Other hedge funds and other institutional investors have also recently made changes to their positions in the company. LGT Financial Advisors LLC boosted its holdings in shares of GE HealthCare Technologies by 46.2% in the fourth quarter. LGT Financial Advisors LLC now owns 389 shares of the company's stock worth $30,000 after buying an additional 123 shares during the last quarter. Integrated Wealth Concepts LLC raised its position in GE HealthCare Technologies by 0.7% in the fourth quarter. Integrated Wealth Concepts LLC now owns 17,173 shares of the company's stock worth $1,343,000 after acquiring an additional 126 shares during the period. Knuff & Co LLC boosted its stake in shares of GE HealthCare Technologies by 1.5% during the 1st quarter. Knuff & Co LLC now owns 10,276 shares of the company's stock worth $829,000 after acquiring an additional 150 shares during the last quarter. Graypoint LLC boosted its stake in shares of GE HealthCare Technologies by 5.7% during the 1st quarter. Graypoint LLC now owns 3,028 shares of the company's stock worth $244,000 after acquiring an additional 162 shares during the last quarter. Finally, Ferguson Wellman Capital Management Inc. grew its position in shares of GE HealthCare Technologies by 3.2% during the 1st quarter. Ferguson Wellman Capital Management Inc. now owns 5,336 shares of the company's stock valued at $431,000 after acquiring an additional 166 shares during the period. Hedge funds and other institutional investors own 82.06% of the company's stock.
GE HealthCare Technologies Price Performance
Shares of GE HealthCare Technologies stock opened at $74.09 on Wednesday. The company has a market capitalization of $33.83 billion, a price-to-earnings ratio of 15.18, a PEG ratio of 2.85 and a beta of 1.13. The company has a quick ratio of 0.93, a current ratio of 1.16 and a debt-to-equity ratio of 0.85. The stock's 50-day simple moving average is $74.10 and its 200-day simple moving average is $74.95. GE HealthCare Technologies Inc. has a 52 week low of $57.65 and a 52 week high of $94.80.
GE HealthCare Technologies (NASDAQ:GEHC - Get Free Report) last released its earnings results on Wednesday, July 30th. The company reported $1.06 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.91 by $0.15. GE HealthCare Technologies had a return on equity of 23.93% and a net margin of 11.22%.The firm had revenue of $5 billion during the quarter, compared to analysts' expectations of $4.96 billion. During the same quarter last year, the business posted $1.00 earnings per share. The firm's revenue was up 3.5% on a year-over-year basis. GE HealthCare Technologies has set its FY 2025 guidance at 4.430-4.630 EPS. As a group, analysts expect that GE HealthCare Technologies Inc. will post 4.68 earnings per share for the current fiscal year.
GE HealthCare Technologies declared that its Board of Directors has authorized a share buyback program on Wednesday, April 30th that authorizes the company to buyback $1.00 billion in shares. This buyback authorization authorizes the company to buy up to 3.1% of its stock through open market purchases. Stock buyback programs are usually an indication that the company's board believes its shares are undervalued.
GE HealthCare Technologies Dividend Announcement
The business also recently disclosed a quarterly dividend, which was paid on Friday, August 15th. Stockholders of record on Friday, July 25th were given a dividend of $0.035 per share. The ex-dividend date was Friday, July 25th. This represents a $0.14 annualized dividend and a dividend yield of 0.2%. GE HealthCare Technologies's dividend payout ratio (DPR) is presently 2.87%.
Analyst Ratings Changes
A number of equities analysts recently commented on the company. Wall Street Zen raised GE HealthCare Technologies from a "hold" rating to a "buy" rating in a report on Saturday, May 31st. Wells Fargo & Company reduced their price target on GE HealthCare Technologies from $103.00 to $89.00 and set an "overweight" rating for the company in a research report on Thursday, May 1st. UBS Group raised GE HealthCare Technologies from a "sell" rating to a "neutral" rating and decreased their price objective for the stock from $74.00 to $73.00 in a research note on Monday, May 5th. BTIG Research reaffirmed a "buy" rating on shares of GE HealthCare Technologies in a research report on Monday, July 14th. Finally, The Goldman Sachs Group reduced their target price on shares of GE HealthCare Technologies from $94.00 to $82.00 and set a "buy" rating for the company in a report on Thursday, May 1st. Eight investment analysts have rated the stock with a Buy rating and three have given a Hold rating to the company. Based on data from MarketBeat, the company has a consensus rating of "Moderate Buy" and an average target price of $88.55.
Check Out Our Latest Analysis on GEHC
About GE HealthCare Technologies
(
Free Report)
GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.
Featured Articles
Want to see what other hedge funds are holding GEHC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for GE HealthCare Technologies Inc. (NASDAQ:GEHC - Free Report).
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider GE HealthCare Technologies, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and GE HealthCare Technologies wasn't on the list.
While GE HealthCare Technologies currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
MarketBeat All Access